1 Department of Translational Research and Cellular Therapeutics, and Diabetes and Metabolism Research Institute and Beckman Research Institute of City of Hope , Duarte, California.
2 The Irell and Manella Graduate School of Biological Sciences, and Diabetes and Metabolism Research Institute and Beckman Research Institute of City of Hope , Duarte, California.
Stem Cells Dev. 2018 Jul 1;27(13):898-909. doi: 10.1089/scd.2017.0160. Epub 2018 Jun 6.
Pluripotent stem cells may serve as an alternative source of beta-like cells for replacement therapy of type 1 diabetes; however, the beta-like cells generated in many differentiation protocols are immature. The maturation of endogenous beta cells involves an increase in insulin expression starting in late gestation and a gradual acquisition of the abilities to sense glucose and secrete insulin by week 2 after birth in mice; however, what molecules regulate these maturation processes are incompletely known. In this study, we aim to identify small molecules that affect immature beta cells. A cell-based assay, using pancreatic beta-like cells derived from murine embryonic stem (ES) cells harboring a transgene containing an insulin 1-promoter driven enhanced green fluorescent protein reporter, was used to screen a compound library (NIH Clinical Collection-003). Cortisone, a glucocorticoid, was among five positive hit compounds. Quantitative reverse transcription-polymerase chain reaction analysis revealed that glucocorticoids enhance the gene expression of not only insulin 1 but also glucose transporter-2 (Glut2; Slc2a2) and glucokinase (Gck), two molecules important for glucose sensing. Mifepristone, a pharmacological inhibitor of glucocorticoid receptor (GR) signaling, reduced the effects of glucocorticoids on Glut2 and Gck expression. The effects of glucocorticoids on ES-derived cells were further validated in immature primary islets. Isolated islets from 1-week-old mice had an increased Glut2 and Gck expression in response to a 4-day treatment of exogenous hydrocortisone in vitro. Gene deletion of GR in beta cells using rat insulin 2 promoter-driven Cre crossed with GR mice resulted in a reduced gene expression of Glut2, but not Gck, and an abrogation of insulin secretion when islets were incubated in 0.5 mM d-glucose and stimulated by 17 mM d-glucose in vitro. These results demonstrate that glucocorticoids positively regulate glucose sensors in immature murine beta-like cells.
多能干细胞可以作为替代 1 型糖尿病的β样细胞的来源;然而,许多分化方案中产生的β样细胞不成熟。内源性β细胞的成熟涉及从妊娠后期开始胰岛素表达的增加,以及在出生后第 2 周逐渐获得感知葡萄糖和分泌胰岛素的能力;然而,调节这些成熟过程的分子尚不完全清楚。在这项研究中,我们旨在确定影响不成熟β细胞的小分子。使用源自携带胰岛素 1 启动子驱动增强型绿色荧光蛋白报告基因的转基因的鼠胚胎干细胞衍生的胰岛样细胞的基于细胞的测定法筛选化合物文库(NIH 临床收集 003)。皮质酮,一种糖皮质激素,是五种阳性命中化合物之一。定量逆转录聚合酶链反应分析显示,糖皮质激素不仅增强胰岛素 1 的基因表达,还增强葡萄糖转运蛋白-2(Slc2a2)和葡糖激酶(Gck)的基因表达,这两种分子对于葡萄糖感应很重要。米非司酮,一种糖皮质激素受体(GR)信号转导的药理学抑制剂,降低了糖皮质激素对 Glut2 和 Gck 表达的影响。糖皮质激素对 ES 衍生细胞的影响在不成熟的原代胰岛中进一步得到验证。从 1 周龄小鼠分离的胰岛在体外用外源性氢化可的松处理 4 天,Glut2 和 Gck 的表达增加。使用大鼠胰岛素 2 启动子驱动 Cre 与 GR 小鼠交叉进行β细胞中 GR 的基因缺失导致 Glut2 的基因表达减少,但 Gck 没有减少,并且当胰岛在 0.5 mM d-葡萄糖中孵育并在体外受到 17 mM d-葡萄糖刺激时,胰岛素分泌被阻断。这些结果表明,糖皮质激素正向调节不成熟的鼠β样细胞中的葡萄糖传感器。